Vertex to participate in upcoming march investor conferences

Boston--(business wire)--vertex pharmaceuticals incorporated (nasdaq: vrtx) today announced management participation in three upcoming investor conferences. stuart arbuckle, executive vice president and chief operating officer, and david altshuler, m.d., ph.d., executive vice president, global research, and chief scientific officer will participate in a fireside chat at the td cowen 45th annual health care conference on monday, march 3, 2025, at 3:10 p.m. et. charles wagner, executive vice pres.
VRTX Ratings Summary
VRTX Quant Ranking